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Abstract 
Background: Mitochondrial disorders are underdiagnosed and the variable symptomatology 
can mimic somatoform disorder.  
Method: Case report of a woman with multisystemic symptomatology arising from 
mitochondrial dysfunction diagnosed as somatoform disorder which impaired her eligibility 
for incapacity benefit. 
Result: Longitudinal follow-up, the synthesis of clinical symptoms and laboratory data of the 
reported case suggested mitochondrial disease. Genetic testing proved the presence of the 
A3243G base substitution, the most common mutation of the mitochondrial DNA presenting 
as MELAS syndrome. 
Conclusion: The authors wish to demonstrate the importance of multidisciplinary approach in 
the diagnostic process when symptoms of somatoform are present. 
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Background 
Mitochondrial dysfunction was first described in a patient who was losing weight despite 
normal thyroid function [1]. Mutations of the mitochondrial DNA (mtDNA) compromise 
oxidative phosporylation and cause ATP deficiency, affecting multiple organs in varying 
location and severity. Due to clinical heterogeneity, mitochondrial disorders are 
underdiagnosed, patients tipically see multiple specialists and have several parallel diagnosis 
[2]. Somatoform disorder is a common stigmatizing misdiagnosis as it was the case for the 
woman described.  
 
Case presentation 
The 50-year-old female patient had normal childhood development. She came through 
common childhood infections and at age 6 had a few months period of frequent vomiting. Lab 
results showed acetonaemia and iron-deficiency anemia.  In her teenage years she was treated 
for arthritis. Around the age of 20 she had two car accidents, both resulting in multiple limb 
fractures and concussion of the head. After the second accident, the patient complained of 
hearing impairment. X-ray revealed block formation of the C5/C6 vertebrae and the hearing 
impairment was assumed to be part of a post-concussion syndrome. Nootropics were 
administered without effect. She also complained of severe episodic headaches, associated 
with vertigo and nausea. CT scan detected calcification of the basal ganglia, slightly 
decreased levels of parathyroid hormone and serum calcium. An abnormality in calcium 
metabolism was suspected but was not further explored. Although the patient achieved 
secondary level education she was unable to keep even undemanding jobs due to fatigue and 
headache for which the adrenergic vasopressor pholedrine proved to be the only effective 
treatment. The patient was found eligible for an incapacity benefit. 
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A few years later, still in her twenties, inflammation of multiple organs was observed 
including pyelonephritis, chronic hepatitis, pancreatitis, jejunitis and terminal ileitis resulting 
in the atrophy of the intestinal mucosa. She was losing weight due to lactose intolerance and 
malabsorption. Results of routine blood, liver and kidney function tests were normal. The 
heterozygotic form of cystic fibrosis was hypothesised but got challenged by a negative sweat 
test. The patient also complained of dysmenorrhoea. Endocrinologic profile was normal 
except for an elevated prolactine level that normalized spontaneously. Multiple adnexitis was 
found and – despite hydrotubation and abrasion of the occluded tubes – total amenorrhea and 
postmenopausal osteoporosis developed. Dysthymia was also diagnosed but was not treated. 
In her thirties, progression of the conductive hearing impairment as well as transient paralysis 
of the right arm was observed. Neurological examination found hypotrophic limb muscles, 
mild truncal ataxia, and decreased deep tendon reflexes on the lower extremities.  
When the patient was 40, reevaluation of incapacity benefit took place and the revising 
physician gave the summarizing diagnosis of somatoform disorder. No psychiatric treatment 
was offered but the patient’s incapacity benefit got reduced. 
A few years later, apraxia and resting tremor of the hands developed and an extensive workup 
took place. A CT scan showed progression of the calcification in the basal ganglia with 
confluating ischemic lesions periventricularly on both sides. MRI scan found multiple 
demyelinating lesions in the occipital lobe, the semioval center, at the side, the frontal horn 
and the trigone of the lateral ventricles. Immunological investigation found elevated levels of 
albumin and IgG both in the serum and the CSF, but oligoclonal bands were not present. EEG 
examinations revealed theta-beta paroxysms with frontal lobe dominance and occasional 
spikes, provoked by hyperventillation. Based on these findings, the possibility of Fahr-
syndrome and CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts 
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and leukoencephalopathy) arised. The patient was put on long-term disability status and was 
referred to our center for further investigations.  
On assessment in our center, sequence analysis did not find alteration in the NOTCH3 gene. 
However, an elevated level of resting serum lactate (4 mmol/l), CK (creatine kinase, 305 U/l) 
and LDH (lactate dehydrogenase, 490 U/l) were found. Neurological examination depicted 
bilateral ptosis, dysarthria, diffusely hypotrophic muscles, latent paresis of the right arm, 
distal hypoesthesia in all limbs, generalized areflexia and marked truncal ataxia. Psychiatric 
assessment showed subclinical depression with the Beck Depression Inventory-Short Form 
and Hamilton Derpession Rating Scale (8 and 9 point, respectively), structured clinical 
interviews (SCID-I and SCID-II) detected no psychopathology. Neuropsychological 
assessment measured an IQ of 92, a PQ (performance quotient) and a VQ (verbal quotient) of 
93 which is a balanced but subnormal profile. Task performance was slowed, short- and long-
term memory were both impaired. Family anamnesis was positive for head tremor of the 
mother, beginning at the age of 70.  
Revision of the patient’s medical history, the clinical picture together with laboratory data 
suggested mitochondrial dysfunction. The diagnosis was confirmed by myopathological and 
genetic investigation. Muscle biopsy showed histological alterations characteristic of 
mitochondrial disease such as typical ragged blue and COX (cytochrome oxidase) negative 
fibers. Electron microscopy detected intramitochondrial paracrystallin inclusions 
intermyofibrillary enlarged pleioclonal mitochondria with pathological structure. Genetic 
analysis of the mtDNA revealed the A3243G nucleotide substitution (with a heteroplasmy 
rate of 35%). This is the most common mtDNA mutation, resulting in MELAS syndrome 
(myoclonus epilepsy, lactic acidosis, stroke-like episodes), explaining the diverse nature of 
the patient’s symptomatology. 
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Discussion 
Multisystemic conditions are often mistaken for somatization while patients with true 
somatoform disorder often present to general medical settings rather than mental health 
settings and undergo multiple workup, pharmacological treatments and even surgeries [3]. 
Diagnostic subcategories of somatoform disorder are being radically reviewed for the DSM-V 
[4] in order to make them more reliable [3, 5-9] as there is currently a great heterogeneity in 
how physicians identify and manage affected patients [10]. In our case some of the symptoms 
- transient paralysis of an arm or leg, hearing loss and seizures - are characteristics of 
conversion disorder. Others, like headache, fatigue, digestive symptoms, could be signs of 
somatization disorder. Psychiatric diagnosis in general and somatoform disorders themselves 
are known to cause high perceived stigma to the patients [11] even from healthcare workers 
[12]. For our patient the (mis)diagnosis even resulted in evident negative discrimination in the 
evalutation process for incapacity benefit. Headache and fatigue, the most debilitating 
symptoms were considered an insufficient basis for chronic, total incapacity. 'Subjective' 
impairments has yet been long cited as the sole manifestation of a variety of conditions which 
feature prominently among claims for incapacity benefits and long-term disability [13]. The 
establishment of a comprehensive and reasoned approach to judging the functional impact of 
'subjective' impairment is an issue of great importance [13].  
Objective findings in the presented case were ignored possibly due to the clinician’s 
frustration of not being able to understand and integrate the symptomatology. Teamwork, 
consultation between different specialists in complicated multisystemic diseases is essential. 
Given the high energy demand of the central nervous system, neurologic and psychiatric 
symptoms are common in mitochondrial disorder. Keeping in mind a possible mitochondrial 
dysfunction and a holistic view can make the proper and early diagnosis of multisystemic 
diseases a reality.  
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Conclusion 
This case report suggests that in multisystemic cases where the signs of a somatoform 
disorder are combined with laboratory abnormalities - like elevated resting lactate and CK 
levels - and a positive family anamnesis, mitochondrial workup is warranted to avoid 
misdiagnosis. 
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